F Le Boeuf
Overview
Explore the profile of F Le Boeuf including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
43
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Roy D, Power A, Bourgeois-Daigneault M, Falls T, Ferreira L, Stern A, et al.
J Control Release
. 2015 Oct;
220(Pt A):210-221.
PMID: 26482080
Due to cancer's genetic complexity, significant advances in the treatment of metastatic disease will require sophisticated, multi-pronged therapeutic approaches. Here we demonstrate the utility of a Drosophila melanogaster cell platform...
2.
Ruotsalainen J, Kaikkonen M, Niittykoski M, Martikainen M, Lemay C, Cox J, et al.
Gene Ther
. 2014 Sep;
22(1):65-75.
PMID: 25231172
In our earlier studies, Semliki Forest virus vector VA7 completely eliminated type I interferon (IFN-I)-unresponsive human U87-luc glioma xenografts, whereas interferon-responsive mouse gliomas proved refractory. Here, we describe in two...
3.
Batenchuk C, Le Boeuf F, Stubbert L, Falls T, Atkins H, Bell J, et al.
Blood Cancer J
. 2014 Apr;
4:e201.
PMID: 24727997
No abstract available.
4.
Batenchuk C, Le Boeuf F, Stubbert L, Falls T, Atkins H, Bell J, et al.
Blood Cancer J
. 2013 Jul;
3:e123.
PMID: 23852158
Rhabdoviruses (RVs) are currently being pursued as anticancer therapeutics for various tumor types, notably leukemia. However, modest virion production and limited spread between noncontiguous circulating leukemic cells requires high-dose administration...